Literature DB >> 2512134

First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject.

P Bürgisser1, L Odier, J Schüpbach, P C Frei.   

Abstract

Few cases of human immunodeficiency virus type 2 (HIV-2) infection have been reported in individuals other than of West African origin. The first well documented case of HIV-2 infection observed in a Swiss subject is presented here. The 50-year-old woman had a sexual relationship with a Senegalese man, who was later shown to be HIV seropositive. Initially, the subject's serum was tested using a routine screening assay for the detection of HIV-1 antibodies. This assay elicited a borderline positive result. A confirmatory competitive EIA and a Western blot test for anti-HIV-1 antibodies showed a positive reaction with gag and pol proteins of HIV-1, but not with env proteins. Thus, HIV-2 infection was suspected and subsequently confirmed by three different methods, including Western blot analysis and an HIV-1/HIV-2 differentiation test. This case emphasizes the need for screening with combined HIV-1/HIV-2 tests.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512134     DOI: 10.1007/bf01963776

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  A preliminary evaluation of five HIV antigen detection assays.

Authors:  D S Healey; W J Maskill; E V Neate; F Beaton; I D Gust
Journal:  J Virol Methods       Date:  1988-06       Impact factor: 2.014

2.  HIV-2 infection in the United States.

Authors:  J Z Ayanian; J H Maguire; R G Marlink; M Essex; P J Kanki
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

3.  Predictions of linear T-cell and B-cell epitopes in proteins encoded by HIV-1, HIV-2 and SIVMAC and the conservation of these sites between strains.

Authors:  M J Zvelebil; M J Sternberg; J Cookson; A R Coates
Journal:  FEBS Lett       Date:  1988-12-19       Impact factor: 4.124

4.  Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.

Authors:  J Goudsmit; J M Lange; D A Paul; G J Dawson
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

5.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 6.  West African human retroviruses related to STLV-III.

Authors:  P J Kanki
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

7.  The global distribution of human immunodeficiency virus type 2 (HIV-2) infection.

Authors:  C R Horsburgh; S D Holmberg
Journal:  Transfusion       Date:  1988 Mar-Apr       Impact factor: 3.157

8.  Genome organization and transactivation of the human immunodeficiency virus type 2.

Authors:  M Guyader; M Emerman; P Sonigo; F Clavel; L Montagnier; M Alizon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

Review 9.  HIV-2, the West African AIDS virus.

Authors:  F Clavel
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

10.  Human retroviral infections in The Gambia: prevalence and clinical features.

Authors:  D C Mabey; R S Tedder; A S Hughes; P T Corrah; S J Goodison; T O'Connor; F C Shenton; S B Lucas; H C Whittle; B M Greenwood
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09
View more
  2 in total

1.  Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope.

Authors:  M L Huang; M Essex; T H Lee
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Epidemiology of HIV-2 infection in Spain. The HIV-2 Spanish Study Group.

Authors:  V Soriano; M Gutiérrez; E Caballero; G Cilla; J L Fernández; A Aguilera; C Tuset; F Dronda; A M Martín; E Carballo; I López; J González-Lahoz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.